urea has been researched along with Candidiasis in 20 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Candidiasis: Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The kinetic interactions among glucose, alanine, and urea metabolism were studied in both normal volunteers and in patients with sepsis by means of a primed, constant infusion of stable isotopes." | 7.67 | Assessment of alanine, urea, and glucose interrelationships in normal subjects and in patients with sepsis with stable isotopic tracers. ( Klein, S; Shaw, JH; Wolfe, RR, 1985) |
| "These results suggest that the topical treatment of onychomycosis by occlusive dressing is a useful method for those patients who have difficulties in or do not wish to be treated with oral antifungal agents." | 6.69 | [Topical treatment of onychomycosis by occlusive dressing using bifonazole cream containing 40% urea]. ( Higashi, N; Kasai, T; Kitamura, K; Komatsuzaki, H; Nakashima, Y; Nishimoto, K; Ogawa, H; Oka, K; Takiuchi, I; Tsuboi, R; Unno, K, 1998) |
| "Amphotericin B can cause significant toxicity but this can be reduced by direct dilution into a fat emulsion (Intralipid)." | 5.30 | In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits. ( Bonnin, A; Buisson, M; Chavanet, P; Dubois, C; Duong, M; Hamel, H; Portier, H, 1997) |
| "The kinetic interactions among glucose, alanine, and urea metabolism were studied in both normal volunteers and in patients with sepsis by means of a primed, constant infusion of stable isotopes." | 3.67 | Assessment of alanine, urea, and glucose interrelationships in normal subjects and in patients with sepsis with stable isotopic tracers. ( Klein, S; Shaw, JH; Wolfe, RR, 1985) |
| " Clinical tests showed a strong proteinuria, high levels of blood urea and creatinine, and a low GOT increase." | 3.66 | [Experimental pathogenicity of Candida lusitaniae in mice]. ( De Bernardis, F; Morelli, L; Tuttobello, L, 1981) |
| "These results suggest that the topical treatment of onychomycosis by occlusive dressing is a useful method for those patients who have difficulties in or do not wish to be treated with oral antifungal agents." | 2.69 | [Topical treatment of onychomycosis by occlusive dressing using bifonazole cream containing 40% urea]. ( Higashi, N; Kasai, T; Kitamura, K; Komatsuzaki, H; Nakashima, Y; Nishimoto, K; Ogawa, H; Oka, K; Takiuchi, I; Tsuboi, R; Unno, K, 1998) |
| "Amphotericin B can cause significant toxicity but this can be reduced by direct dilution into a fat emulsion (Intralipid)." | 1.30 | In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits. ( Bonnin, A; Buisson, M; Chavanet, P; Dubois, C; Duong, M; Hamel, H; Portier, H, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (45.00) | 18.7374 |
| 1990's | 3 (15.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Orofino, F | 1 |
| Truglio, GI | 1 |
| Fiorucci, D | 1 |
| D'Agostino, I | 1 |
| Borgini, M | 1 |
| Poggialini, F | 1 |
| Zamperini, C | 1 |
| Dreassi, E | 1 |
| Maccari, L | 1 |
| Torelli, R | 1 |
| Martini, C | 1 |
| Bernabei, M | 1 |
| Meis, JF | 1 |
| Khandelwal, NK | 1 |
| Prasad, R | 1 |
| Sanguinetti, M | 1 |
| Bugli, F | 1 |
| Botta, M | 1 |
| Geiser, DM | 1 |
| Davis, SA | 1 |
| Vincent, BM | 1 |
| Endo, MM | 1 |
| Whitesell, L | 1 |
| Marchillo, K | 1 |
| Andes, DR | 1 |
| Lindquist, S | 1 |
| Burke, MD | 1 |
| Bray, N | 1 |
| Navarathna, DHMLP | 1 |
| Das, A | 1 |
| Morschhäuser, J | 1 |
| Nickerson, KW | 2 |
| Roberts, DD | 2 |
| Navarathna, DH | 1 |
| Lionakis, MS | 1 |
| Lizak, MJ | 1 |
| Munasinghe, J | 1 |
| BROWN, CP | 1 |
| WILSON, FH | 1 |
| DICKSTEIN, B | 1 |
| ANDRIOLE, VT | 1 |
| EPSTEIN, FH | 1 |
| Liao, WL | 1 |
| Ramón, AM | 1 |
| Fonzi, WA | 1 |
| White, MI | 1 |
| Clayton, YM | 1 |
| Tuttobello, L | 1 |
| De Bernardis, F | 1 |
| Morelli, L | 1 |
| Chavanet, P | 1 |
| Duong, M | 1 |
| Buisson, M | 1 |
| Hamel, H | 1 |
| Dubois, C | 1 |
| Bonnin, A | 1 |
| Portier, H | 1 |
| Tsuboi, R | 1 |
| Unno, K | 1 |
| Komatsuzaki, H | 1 |
| Ogawa, H | 1 |
| Kasai, T | 1 |
| Oka, K | 1 |
| Takiuchi, I | 1 |
| Kitamura, K | 1 |
| Higashi, N | 1 |
| Nakashima, Y | 1 |
| Nishimoto, K | 1 |
| Budak, A | 1 |
| Ryley, JF | 1 |
| McGregor, S | 1 |
| Lister, SC | 1 |
| Jackson, KP | 1 |
| Shaw, JH | 1 |
| Klein, S | 1 |
| Wolfe, RR | 1 |
| Fauser, U | 1 |
| Malchow, H | 1 |
| Seybold, D | 1 |
| Lange, H | 1 |
| Freund, J | 1 |
| Rüger, K | 1 |
1 trial available for urea and Candidiasis
| Article | Year |
|---|---|
[Topical treatment of onychomycosis by occlusive dressing using bifonazole cream containing 40% urea].
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Female; Hum | 1998 |
19 other studies available for urea and Candidiasis
| Article | Year |
|---|---|
In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains.
Topics: Animals; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Fungal; Guanidine; Microb | 2020 |
Antifungal design: The toxicity-resistance yin-yang.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; U | 2015 |
Nontoxic antimicrobials that evade drug resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Binding Sites; Candida; Candidiasis; Cell Line; Cell Sur | 2015 |
Antifungal drugs: Designer non-toxic derivatives dodge resistance.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Humans; U | 2015 |
Fungal nail infections: diagnosis and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Azoles; Candidiasis; Drug Therapy, | 2009 |
Dur3 is the major urea transporter in Candida albicans and is co-regulated with the urea amidolyase Dur1,2.
Topics: Animals; Candida albicans; Candidiasis; Carbon Radioisotopes; Carbon-Nitrogen Ligases; Fungemia; Gen | 2011 |
Urea amidolyase (DUR1,2) contributes to virulence and kidney pathogenesis of Candida albicans.
Topics: Animals; Candida albicans; Candidiasis; Carbon-Nitrogen Ligases; Female; Fungal Proteins; Gene Expre | 2012 |
DIAPER REGION IRRITATIONS. PERTINENT FACTS AND METHODS OF PREVENTION.
Topics: Ammonia; Ammonium Compounds; Anilides; Anti-Infective Agents, Local; Bacillus subtilis; Candidiasis; | 1964 |
NEONATAL ORAL CANDIDIASIS: EVALUATION OF A NEW CHEMOTHERAPEUTIC AGENT.
Topics: Antineoplastic Agents; Candidiasis; Candidiasis, Oral; Dermatologic Agents; Glycerol; Humans; Infant | 1964 |
PREVENTION OF PYELONEPHRITIS BY WATER DIURESIS: EVIDENCE FOR THE ROLE OF MEDULLARY HYPERTONICITY IN PROMOTING RENAL INFECTION.
Topics: Ammonia; Biochemical Phenomena; Biochemistry; Candidiasis; Diuresis; Kidney; Potassium; Pyelonephrit | 1965 |
GLN3 encodes a global regulator of nitrogen metabolism and virulence of C. albicans.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fun | 2008 |
The treatment of fungus and yeast infections of nails by the method of "chemical removal'.
Topics: Candidiasis; Dermatomycoses; Female; Humans; Middle Aged; Nail Diseases; Ointments; Urea | 1982 |
[Experimental pathogenicity of Candida lusitaniae in mice].
Topics: Animals; Aspartate Aminotransferases; Brain Chemistry; Candida; Candidiasis; Cell Count; Creatinine; | 1981 |
In-vivo activity and tolerance of conventional formulation versus fat emulsion formulation of amphotericin B in experimental disseminated candidiasis in neutropenic rabbits.
Topics: Amphotericin B; Animals; Candidiasis; Creatinine; Fat Emulsions, Intravenous; Glucose; Kidney; Male; | 1997 |
Epidemiology of Candida infection. III. A proposal for a new typing system for Candida albicans strains.
Topics: Bacterial Typing Techniques; Candida albicans; Candidiasis; Evaluation Studies as Topic; Humans; Kil | 1990 |
Kidney function in experimental systemic candidosis of mice.
Topics: Animals; Candida albicans; Candidiasis; Creatinine; Diuresis; Kidney; Kidney Function Tests; Mice; U | 1988 |
Assessment of alanine, urea, and glucose interrelationships in normal subjects and in patients with sepsis with stable isotopic tracers.
Topics: Adult; Aged; Alanine; Blood Glucose; Candidiasis; Carbon Isotopes; Escherichia coli Infections; Fema | 1985 |
[Successful treatment of Candida septicaemia and interstitial pneumonia].
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Benzene Derivatives; Bronchopneumon | 1973 |
[Successful treatment of candida sepsis with the oral antimycotic Bay b 5097].
Topics: Acute Kidney Injury; Antifungal Agents; Benzene Derivatives; Blood; Candidiasis; Creatinine; Eye Man | 1972 |